Picker features short-bore MRI magnets

Article

MRI will be the featured attraction in Picker's booth (Hall B, #7548). The company in August debuted two new short-bore MRI magnets, the 1.5-tesla Edge Eclipse and 1-tesla Vista Polaris, which are 22% shorter and 30% lighter than their predecessors (SCAN

MRI will be the featured attraction in Picker's booth (Hall B, #7548). The company in August debuted two new short-bore MRI magnets, the 1.5-tesla Edge Eclipse and 1-tesla Vista Polaris, which are 22% shorter and 30% lighter than their predecessors (SCAN 8/20/97). Either system can be installed in 325 sq ft of floor space, have patient apertures of 61 cm, and patient bores that are 6 ft long.

Both systems have powerful 27 mtesla/m gradients, and Picker will display an optimization protocol called AcuScan that squeezes additional performance out of the gradients, according to Linda Eastwood, MR marketing manager for the Cleveland company.

New areas of research for Picker include the use of MRI for early detection of stroke, in which a brain exam could help clinicians treat patients with tissue plasminogen activator (tPA) and anti-clotting drugs.

For the 0.5-tesla Asset scanner, Picker has added PowerDrive 100 gradients, bringing the system's specifications up to a 16 mtesla/m peak rating with a slew rate of 25 mtesla/m/msec.

In the realm of MRI research, Picker will show its latest work in MRI-guided procedures by integrating Outlook with the ViewPoint image-guided surgery workstation. The company will also show three levels of MRI-guided procedure capability, Eastwood said, with the most advanced capability including Outlook, Viewpoint, and MRI-compatible surgical tools.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.